Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
Human respiratory syncytial virus (HRSV) is the leading cause of bronchiolitis and pneumonia in infants, children, the elderly and the immune-compromised. The goal of immunization is to provide sufficient protection to prevent serious lower respiratory tract diseases leading to hospitalization and r...
محفوظ في:
المؤلف الرئيسي: | Jalilian, Farid Azizi |
---|---|
التنسيق: | أطروحة |
اللغة: | English English |
منشور في: |
2011
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://psasir.upm.edu.my/id/eprint/19448/1/FBSB_2011_3_F.pdf |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
بواسطة: Suhaimi, Siti Syazani
منشور في: (2011) -
A study of children with respiratory syncytial virus (RSV) infection admitted to sabah women and children's Hospital (SWACH) Kota Kinabalu, Sabah /
بواسطة: Chia, Kelvin Cheong Yung
منشور في: (2013) -
Genotypic and phenotypic differences in respiratory syncytial virus subtypes A and B /
بواسطة: Khor, Chee Sieng -
Investigating the role of autophagy in regulating innate cytokine response of human lung epithelial cells to respiratory syncytial virus
بواسطة: Azman, Nur Amiera Fatin
منشور في: (2021) -
Respiratory syncytial virus chest infection in University Hospital, Kuala Lumpur /
بواسطة: Chan, Patrick Wai Kiong
منشور في: (1997)